Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02773589
Other study ID # 5368
Secondary ID
Status Completed
Phase N/A
First received May 9, 2016
Last updated June 30, 2017
Start date March 2014
Est. completion date April 2017

Study information

Verified date May 2016
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Achalasia is an esophagus motor disability characterized by a lack of relaxation of the lower esophageal sphincter (LES) to deglutition. Myotomy is the gold standard surgical technique allowing to cure this pathology. In this study, investigators are using a new endoluminal technique of myotomy, innovative and less invasive, called POEM (PerOral Endoscopic Myotomy). This technique does not require any cutaneous incision.

Mini-invasive surgery is more and more associated to endoscopy. The practice was initiated by the accession of natural orifice transluminal endoscopic surgery (NOTES). In this context, the introduction of the POEM technique seems to be an original approach and a natural evolution to a new generation of surgical endoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 2017
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Esophagus achalasia

- Confirmed by esophageal manometry

- Requiring surgical care

- No contraindication to general anesthesia

- BMI under 40 kg/m²

- Ability to give an informed consent

- Candidate to elective Heller's myotomy

- Affiliation to a social security system

- Signed and informed consent

Exclusion Criteria:

- Advanced esophageal dilatation (sigmoid megaesophagus)

- Previous mediastinal or esophageal surgery

- Contraindication to esophagogastroduodenoscopy (EGD)

- Contraindication to general anesthesia

- BMI above 40 kg/m²

- Infectious esophagitis (e.g. candidiasis)

- Psychiatric context unsuitable with an experimental protocol

- Allergy to beta-lactam

- Contraindication to endoscopy (esophageal stenosis, suspicion of digestive perforation, state of shock, severe anemia, cardiorespiratory failure or severe metabolic disorders)

- Contraindication to monitored pneumoperitoneum (cardiorespiratory failure or severe metabolic disorders)

- Inability to give an informed consent (emergency situations, misunderstanding…)

- Patient in custody

- Patient under guardianship

- Pregnancy or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Peroral endoscopic myotomy
Peroral endoscopic myotomy

Locations

Country Name City State
France University Hospital, Strasbourg, france Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The safety assessment will be based on the reading of all surgical intraoperative complications 6 months post surgery